Post-election consensus on Drug Prices

In a rare steak of bipartisanism after the midterm elections, the President and major congressional leaders have all acknowledge that legislative action on rising drug prices is an area where they could all successfully work together. President Trump has recently put forth a radical Radical proposal to lower drug prices for Medicare. And Rep. Peter Welch, a Vermont Democrat, a vocal proponent of legislation to control drug prices has taken a leadership role on this topic. Senate Majority Leader Mitch McConnell (R-Ky.) also acknowledged that drug prices is an area of opportunity for cooperation across party lines. It is sure to be a battle with the pharmaceutical industry. But perhaps all parties could understand the people’s need for stability and predictability in medication prices while still fostering innovation.  

Read: STAT: Kumbaya in Washington: Democrats, GOP, and Trump all pledge to work to bring down drug prices

Read: STAT: Rep. Peter Welch on drug prices, the potential for bipartisan action, and a ‘broken market’

Beyond the political noise: 3 policy proposals on drug prices that have a fighting chance — and make the industry shudder

Recent Posts

See All

Hi from HIMSS19!

By Albert DiPiero MD MPH I am at the annual HIMSS meeting in Orlando Florida this week. HIMSS is the Healthcare Information and Management Systems Society. A few quick thoughts: The sheer volume of he

CVS explores new concepts in healthcare

By Albert DiPiero MD MPH CVS - the drug store chain which is also one of America's largest retailers - is not waiting to see what Amazon is up to. CVS is pushing ahead transforming itself from retail

Amazon health venture hires CTO

By Albert DiPiero MD MPH The joint healthcare venture between Amazon-Berkshire Hathaway-JP Morgan Chase (ABJ) just announced the hiring of Serkan Kutan as its CTO. Mr Kutan was most recently chief tec